Literature DB >> 10716128

Inflammatory mediators in heart failure.

J Niebauer1.   

Abstract

Cytokines have been identified as a major player in the pathogenesis and the functional status of patients with heart failure. Herein I review studies which are under way to assess the effects of anti-cytokine therapy, where soon we may see treatments directed against bacteria in the bowel, the translocation process, and endotoxin itself, the binding sites of bacterial endotoxin on immune competent cells, or both.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716128     DOI: 10.1016/s0167-5273(99)00190-4

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

Review 1.  Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Authors:  S Møller; J H Henriksen
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

2.  Immunological and histopathological changes in the atrial tissue during and after cardiopulmonary bypass.

Authors:  N Alotti; J Sipos; E Roth; G Kecskés; J Simon; A Rashed; I Kassai
Journal:  Exp Clin Cardiol       Date:  2001

3.  IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart.

Authors:  Indroneal Banerjee; John W Fuseler; Arti R Intwala; Troy A Baudino
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

4.  PKCβII inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses.

Authors:  Suresh Selvaraj Palaniyandi; Julio Cesar Batista Ferreira; Patricia Chakur Brum; Daria Mochly-Rosen
Journal:  J Cell Mol Med       Date:  2011-08       Impact factor: 5.310

5.  Effect of exercise training on interleukin-6, tumour necrosis factor alpha and functional capacity in heart failure.

Authors:  Neil A Smart; Alf I Larsen; John P Le Maitre; Almir S Ferraz
Journal:  Cardiol Res Pract       Date:  2011-02-27       Impact factor: 1.866

6.  Modification of a volume-overload heart failure model to track myocardial remodeling and device-related reverse remodeling.

Authors:  Egemen Tuzun; Roger Bick; Cihan Kadipasaoglu; Jeffrey L Conger; Brian J Poindexter; Igor D Gregoric; O H Frazier; Jeffrey A Towbin; Branislav Radovancevic
Journal:  ISRN Cardiol       Date:  2011-07-06

Review 7.  Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and Differences.

Authors:  Aline V Bacurau; Telma F Cunha; Rodrigo W Souza; Vanessa A Voltarelli; Daniele Gabriel-Costa; Patricia C Brum
Journal:  Oxid Med Cell Longev       Date:  2016-01-19       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.